2009 HAA Elections

This spring, alumni will choose five new Harvard Overseers and six new directors for the Harvard Alumni Association (HAA) board.

This spring, alumni will choose five new Harvard Overseers and six new directors for the Harvard Alumni Association (HAA) board. Ballots should arrive by mail by April 15 and are due back in Cambridge by noon on May 29 to be counted. Election results are announced at the HAA’s annual meeting, on the afternoon of Commencement day, June 4. All Harvard degree-holders, except Corporation members and officers of instruction and government, are entitled to vote for Overseer candidates. The election for HAA directors is open to all degree-holders.

For Overseer (six-year term), the candidates are:

Photeine Anagnostopoulos ’81, M.B.A. ’85, New York City. COO, New York City Department of Education.

Joshua Boger, Ph.D. ’79, Cambridge. President, founder, and CEO, Vertex Pharmaceuticals Inc.

Morgan Chu, J.D. ’76, Los Angeles. Partner, Irell and Manella LLP.

Walter Clair ’77, M.D. ’81, M.P.H. ’85, Nashville, Tennessee. Assistant professor of clinical medicine, Vanderbilt University Medical Center; clinical director of cardiac electrophysiology, Vanderbilt Heart and Vascular Institute.

Mark Gearan ’78, Geneva, New York. President, Hobart and William Smith Colleges.

Linda Greenhouse ’68, Bethesda, Maryland. Knight distinguished journalist-in-residence and Goldstein senior fellow in law, Yale Law School.

Margaret A. Levi, Ph.D. ’74, Seattle. Bacharach professor of international studies, University of Washington; professor of politics, University of Sydney.

Cristian Samper, Ph.D. ’92, Washington, D.C. Director, National Museum of Natural History, Smithsonian Institution.

In addition, at least two alumni are apparently running as petition candidates for Overseer:

Robert L. Freedman ’62, Philadelphia. Partner, Dechert LLP.

Harvey A. Silverglate, LL.B. ’67, Cambridge. Attorney and writer, Good and Cormier.

(The petition-filing deadline, February 9, fell after this issue went to press.)

For Elected Director (three-year term), the candidates are:

Margaret Angell ’98, M.P.A. ’06, Washington, D.C. White House fellow, U.S. Department of Housing and Urban Development.

Paul Choi ’86, J.D. ’89, Chicago. Partner, Sidley Austin LLP.

Carlos Cordeiro ’78, M.B.A. ’80, Hong Kong. Retired partner, Goldman Sachs.

Cindy Maxwell ’92, M.D. ’96, Toronto. Assistant professor of obstetrics and gynaecology and staff perinatologist, Mount Sinai Hospital.

Elizabeth Ryan ’81, Los Angeles. Producer and director for film and television.

Sanford Sacks, M.B.A. ’66, Scarsdale, New York. Consultant, Ambac Assurance Corporation.

Bryan Simmons ’83, New York City. Vice president of marketing and communications, IBM Centennial, International Business Machines Corporation.

John Trasvina ’80, Los Angeles. President and general counsel, Mexican American Legal Defense and Educational Fund.

Meg Vaillancourt ’78, Boston. Vice president, corporate and community affairs, Boston Red Sox.

 

Related topics

You might also like

David Battat promotes alumni engagement.

The president of Harvard Magazine’s Board of Directors will step down in September.

The Harvard-Radcliffe Collegium Musicum reunites for a 50th anniversary tour around France.

Most popular

All That’s Unseen charts the Harvard graduate’s uneasy journey from Appalachia to Cambridge and back.  

After a final round of layoffs, University leaders say 165 staff jobs were eliminated across the division.

Harvard Weathers a Year of Turmoil

The federal government has launched unprecedented actions against the University. Here’s a guide.

Explore More From Current Issue

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.

A football player in a white jersey evades a defender in a green uniform on the field.

Despite personnel losses, Crimson captain Xaviah Bascon is upbeat about the 2026 season.

Two laboratory researchers, one seated and one standing, in a scientific lab with equipment.

The stakes are high for this husband and wife: one of them will die if they don’t find a cure.